T. Shigekiyo et al., HRG TOKUSHIMA - MOLECULAR AND CELLULAR CHARACTERIZATION OF HISTIDINE-RICH GLYCOPROTEIN (HRG) DEFICIENCY, Blood, 91(1), 1998, pp. 128-133
Previously, we found the first congenital deficiency of histidine-rich
glycoprotein (HRG) in a Japanese woman with thrombosis. To elucidate
the genetic basis of this deficiency, we first performed Southern blot
analysis and found no gross deletion or insertion in the proband's HR
G gene, We then examined the nucleotide sequences of all seven exons o
f the proband's HRG gene. A single nucleotide substitution, G to A at
nucleotide position 429, which mutates Gly85 to Glu in the first cysta
tin-like domain, was found in exon 3 in 13 of 22 amplified clones, Thi
s mutation generates a unique Tao I site, Exon 3 was amplified from th
e proband, her family members, and 50 unrelated normal Japanese indivi
duals, and Tao I fragmentation was examined, Fragmentation of exon 3 w
as observed in one allele of the genes from the proband and the family
members who also have decreased plasma levels of HRG. Fifty unrelated
normal Japanese individuals had a normal HRG gene, indicating that th
e G to A mutation is not a common polymorphism, To elucidate the ident
ified mutation as a cause for the secretion defect of HRG in the proba
nd's plasma, we constructed and transiently expressed the recombinant
Tokushima-type HRG mutant (Gly85 to Glu) in baby hamster kidney (BHK)
cells, and examined an intracellular event of the mutant protein, The
results showed that only about 20% of the Tokushima-type HRG was secre
ted into the culture medium, and intracellular degradation of the muta
nt was observed. Thus, the present study strongly suggests that the HR
G deficiency is caused by intracellular degradation of the Gly85 to Gl
u mutant of HRG in the proband. (C) 1998 by The American Society of He
matology.